These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 3498482)

  • 1. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
    Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
    Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
    Wines BD; Easterbrook-Smith SB
    Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-operative interaction of subcomponents of the first component of complement with IgG: a functional defect of dimeric Facb from rabbit IgG.
    Okada M; Udaka K; Utsumi S
    Mol Immunol; 1985 Dec; 22(12):1399-406. PubMed ID: 3007976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-operation between the pair of C gamma 2 domains in Clq-binding by rabbit IgG.
    Udaka K; Okada M; Utsumi S
    Mol Immunol; 1986 Oct; 23(10):1103-10. PubMed ID: 3491952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding site for C1q on IgG.
    Duncan AR; Winter G
    Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C1q binding affects spin-labeled heterosaccharides of rabbit antibodies in immune but not artificial immunoglobulin G aggregates.
    Winkelhake JL; Kusumi A; McKean L; Mandy WJ
    J Biol Chem; 1984 Feb; 259(4):2171-8. PubMed ID: 6199346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin G antibody bound to the C1q subcomponent of human complement exhibits segmental flexibility.
    Hanson DC; Schumaker VN
    J Mol Biol; 1985 Jun; 183(3):377-83. PubMed ID: 3874967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis.
    Strife CF; Leahy AE; West CD
    Kidney Int; 1989 Mar; 35(3):836-42. PubMed ID: 2785226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic interspecies cross-reaction of subcomponent C1q of the first component of complement: evidence for its cross-reaction in both collagen-like and non-collagen-like regions.
    Yonemasu K; Sasaki T; Shimizu A
    J Biochem; 1983 Apr; 93(4):1079-84. PubMed ID: 6408070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of C1q subcomponent with immunoglobulin M.
    Kimak E; Tomaszewski JJ
    Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
    Wisnieski JJ; Naff GB
    Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
    Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG
    Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cleavage of the inter-chain disulphide bonds of rabbit IgG on its ability to bind C1q.
    Sutton J; Alden JR; Easterbrook-Smith SB
    Biochim Biophys Acta; 1984 May; 787(1):39-44. PubMed ID: 6609719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction between fibronectin and aggregated IgG].
    Menzel EJ; Borth W; Kaik B
    Wien Klin Wochenschr; 1983 Dec; 95(24):880-4. PubMed ID: 6608184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.